Drug Target Review: Pinpointing function in cancer T cells could be new immunotherapy
UC research has found that increasing a certain function in cancer T cells could mean a new therapy
A previously unknown T cell mechanism that could explain the reason behind decreased immune function in cancer patients has been discovered. According to University of Cincinnati researchers, their finding may present a new immunotherapeutic target for patients with head and neck cancers.
The study, led by Laura Conforti and Ameet Chimote, in the Division of Nephrology and Hypertension, UC Department of Internal Medicine, revealed that a reduced interaction between a molecule called calmodulin and the ion channel KCa3.1 in the immune cells of cancer patients plays an important role in the limited function of these cells. The team performed experiments on cytotoxic T cells taken from the blood of patients with head and neck cancer.
Featured photo courtesy of Laura Conforti and Ameet Chimote.
Related Stories
University of Cincinnati’s IDD Education Center to Host Ninth Annual Red & Black Blast
December 18, 2025
The University of Cincinnati’s IDD Education Center will host its ninth annual Red & Black Blast on February 25, 2026, at Tangeman University Center. The signature event celebrates and supports the Center’s four programs—CEES, TAP, IMPACT Innovation, and RAAC—which create pathways in education, employment, and community life for individuals with intellectual and developmental disabilities (IDD).
The playbook for lasting corporate-startup partnerships
December 17, 2025
Only 15% of corporate-startup collaborations last, often due to communication challenges and layers of bureaucracy. Here’s how your partnership can beat the odds.
Ohio looks to fast-track wastewater discharge permits
December 16, 2025
Bradford Mank, James B. Helmer Jr. Professor of Law at the University of Cincinnati, spoke with WVXU for a story about a proposal by the Ohio Environmental Protection Agency to streamline the way wastewater discharge permits are issued to data centers.